000174675 000__ 01480fam\a2200325\a\4500
000174675 001__ 174675
000174675 005__ 20220217103528.0
000174675 008__ 890331s1989\\\\dcuk\\\\\\\\\f00010\eng\d
000174675 035__ $$9(IS)TVJ3104
000174675 035__ $$9AAU2977SI
000174675 035__ $$a174675
000174675 040__ $$aGPO$$cGPO
000174675 043__ $$an-us---
000174675 074__ $$a1019-A, 1019-B (microfiche)
000174675 0860_ $$aY 4.En 2/3:100-218
000174675 088__ $$aSerial no. 100-218 (United States. Congress. House. Committee on Energy and Commerce)
000174675 099__ $$aY 4.En 2/3:100-218
000174675 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.$$bSubcommittee on Oversight and Investigations.
000174675 24510 $$aFDA's generic drug application policy :$$bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
000174675 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,$$c1989.
000174675 300__ $$aiii, 19 p. :$$b3 forms ;$$c24 cm.
000174675 500__ $$aDistributed to some depository libraries in microfiche.
000174675 500__ $$aShipping list no.: 89-184-P.
000174675 500__ $$a"Serial no. 100-218."
000174675 61010 $$aUnited States.$$bFood and Drug Administration.
000174675 650_0 $$aGeneric drugs$$zUnited States.
000174675 650_0 $$aDrugs$$zUnited States$$xGeneric substitution.
000174675 650_0 $$aDrugs$$xLaw and legislation$$zUnited States.
000174675 650_0 $$aGovernmental investigations$$zUnited States.
000174675 85230 $$bdfich$$hY 4.EN 2/3:$$i100-218
000174675 909CO $$ooai:library.usi.edu:174675$$pGLOBAL_SET
000174675 948__ $$ac:jk
000174675 980__ $$aBIB
000174675 980__ $$aGOV RESOURCE